amphotericin


Also found in: Dictionary, Thesaurus, Medical.
Related to amphotericin: fluconazole

amphotericin

[‚am·fə′ter·ə·sən]
(microbiology)
An amphoteric antifungal antibiotic produced by Streptomyces nodosus and having of two components, A and B.
References in periodicals archive ?
I went with Paul's brother, Stephen, to see the Care Quality Commission (CQC) in June and to our horror, nothing had been done, three years after Paul's death, on the safety alert about amphotericin, which should have been adhered to by hospitals back in 2007.
Also, in attempt to develop a safe and more powerful antifungal agent from medicinal plants, the combined effect of myrtle oil with amphotericin B were determined.
Confusion over drug Amphotericin was created because the original "conventional" form, branded Fungizone, has a dose of one milligram per kg of patient's weight, but modern forms, Ambizone and Abelcet, have doses of three and five milligrams per kg.
The drug liposomal amphotericin B is expensive at Rs.
After the patient underwent inhaled amphotericin therapy for several weeks, she developed ocular immobility, increased tearing, and subsequent loss of vision in the left eye.
The NPSA said in a statement: "We are recommending that all NHS and independent sector organisations in England and Wales carry out an immediate risk assessment of amphotericin products and procedures, and that managers should communicate the potential risks related to amphotericin to their staff.
The occurrence of severe hyperphosphatemia during treatment with high-dose liposomal amphotericin was reported in a pediatric patient (3), but the possibility of pseudohyperphosphatemia caused by interference of liposomal amphotericin B in the phosphorus assay was not addressed.
For one of these, liposomal amphotericin B, the standard dose in invasive fungal infections is 3 mg/kg per day.
A decade of experience with blastomycosis and its treatment with amphotericin B.
Nystatin and amphotericin B in the treatment of denture-related candidiasis.
Newer amphotericin preparations have been formulated combining amphotericin with lipid structures for intravenous administration.
We are delighted to be able to commercialize the unique, patented BDSI nanocochleate delivery technology using amphotericin B for the indication of chronic rhinosinusitis.